Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CNS Malignancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02975882
What this trial is testing

Nanoparticle Albumin-Bound Rapamycin, Temozolomide, and Irinotecan Hydrochloride in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors

Who this might be right for
Childhood Solid NeoplasmRecurrent Malignant Solid NeoplasmRecurrent Primary Central Nervous System Neoplasm+2 more
Children's Oncology Group 33
Early research (Phase 1)Study completedNCT04022980
What this trial is testing

Nivolumab Consolidation in Older (≥ 65) Patients With Primary CNS Lymphoma

Who this might be right for
Brain and Nervous SystemEye and Orbit
Wake Forest University Health Sciences 14
Not applicableStudy completedNCT00105560
What this trial is testing

Proton Beam Radiation Therapy in Treating Young Patients Who Have Undergone Biopsy or Surgery for Medulloblastoma or Pineoblastoma

Who this might be right for
Brain and Central Nervous System TumorsLong-term Effects Secondary to Cancer Therapy in Children
Massachusetts General Hospital 59
Early research (Phase 1)Study completedNCT00002824
What this trial is testing

Gene Therapy in Treating Patients With Primary Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Abramson Cancer Center at Penn Medicine
Early research (Phase 1)Study completedNCT00272350
What this trial is testing

ZD6474 to Treat Advanced Brain Cancer in Patients

Who this might be right for
Recurrent High-Grade GliomasProgressive Low-Grade GliomasMalignant Gliomas
National Cancer Institute (NCI) 83
Testing effectiveness (Phase 2)Looking for participantsNCT03696680
What this trial is testing

Stereotactic Radiotherapy for Cerebral Metastases with Recent Hemorrhagic Signal

Who this might be right for
Hemorrhagic Brain Metastases
Centre Francois Baclesse 46
Testing effectiveness (Phase 2)WithdrawnNCT00053040
What this trial is testing

Immunotoxin Therapy in Treating Children With Recurrent Malignant Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Pediatric Brain Tumor Consortium
Not applicableUnknownNCT03068520
What this trial is testing

Can Hybrid PET-MRI Differentiate Between Radiation Effects and Disease Progression?

Who this might be right for
Brain Tumor
Assuta Medical Center 140
Not applicableLooking for participantsNCT04692324
What this trial is testing

Cerebrospinal Fluid Biomarkers for Brain Tumors

Who this might be right for
Central Nervous System Neoplasm
Mayo Clinic 400
Not applicableEnded earlyNCT04138524
What this trial is testing

SAFIR© : An Early Intervention for Supporting Families of Patients With Acquired Brain Injuries

Who this might be right for
Acquired Brain Injury
Centre Hospitalier Universitaire Vaudois 12
Early research (Phase 1)Ended earlyNCT00515788
What this trial is testing

DepoCyt Plus Temozolomide in Patients With Neoplastic Meningitis

Who this might be right for
Neoplastic Meningitis
M.D. Anderson Cancer Center 11
Early research (Phase 1)Active Not RecruitingNCT03500991
What this trial is testing

HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors

Who this might be right for
Central Nervous System Tumor, PediatricGliomaEpendymoma+6 more
Seattle Children's Hospital 10
Testing effectiveness (Phase 2)Looking for participantsNCT07227610
What this trial is testing

Brain Metastases in Greater Size - Hypofractionated Options Trial (BIGSHOT)

Who this might be right for
Brain MetastasesCancer (With CNS Involvement)
Medical University of South Carolina 54
Early research (Phase 1)Study completedNCT01518413
What this trial is testing

Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors

Who this might be right for
Rhabdomyosarcoma and Other Soft Tissue SarcomasEwing's Sarcoma Family of TumorsOsteosarcoma+2 more
HMeany 17
Not applicableUnknownNCT03424980
What this trial is testing

Evaluate Effectiveness and Safety of Tyrosine Kinase Inhibitors

Who this might be right for
Non-small Cell Lung Cancer Metastatic
Tang-Du Hospital 200
Testing effectiveness (Phase 2)Study completedNCT00087061
What this trial is testing

Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00025623
What this trial is testing

Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma

Who this might be right for
Neuroblastoma
European Infant Neuroblastoma Study Group - 1999
Early research (Phase 1)UnknownNCT02149459
What this trial is testing

Treatment of Recurrent Brain Tumors: Metabolic Manipulation Combined With Radiotherapy

Who this might be right for
Brain Neoplasms
Sheba Medical Center 18
Not applicableStudy completedNCT03871686
What this trial is testing

Promotion of Well-being of Young Adult Brain Cancer Survivors

Who this might be right for
Brain Tumor, Pediatric
University of Wisconsin, Madison 139
Testing effectiveness (Phase 2)Study completedNCT01977677
What this trial is testing

Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma

Who this might be right for
Adult EpendymoblastomaAdult Giant Cell GlioblastomaAdult Glioblastoma+6 more
Lawrence Recht 30
Next Page